L.Zhang,Y.Zhao.The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road..„J Cell Physiol”.211(3),s.590-7,Jun2007. DOI: 10.1002/jcp.21001. PMID: 17311282.
A.Marson,K.Kretschmer,GM.Frampton,ES.Jacobseni inni.Foxp3 occupancy and regulation of key target genes during T-cell stimulation..„Nature”.445(7130),s.931-5,Feb2007. DOI: 10.1038/nature05478. PMID: 17237765.
CL.Bennett,R.Yoshioka,H.Kiyosawa,DF.Barkeri inni.X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3..„Am J Hum Genet”.66(2),s.461-8,Feb2000. DOI: 10.1086/302761. PMID: 10677306.
M.Takenaka,N.Seki,U.Toh,S.Hattorii inni.FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis..„Mol Clin Oncol”.1(4),s.625-632,Jul2013. DOI: 10.3892/mco.2013.107. PMID: 24649219.
KY.Won,HS.Kim,JY.Sung,GY.Kimi inni.Tumoral FOXP3 has potential oncogenic function in conjunction with the p53 tumor suppressor protein and infiltrated Tregs in human breast carcinomas..„Pathol Res Pract”.209(12),s.767-73,Dec2013. DOI: 10.1016/j.prp.2013.08.010. PMID: 24071443.
CL.Bennett,J.Christie,F.Ramsdell,ME.Brunkowi inni.The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3..„Nat Genet”.27(1),s.20-1,Jan2001. DOI: 10.1038/83713. PMID: 11137993.
L.Zhang,Y.Zhao.The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road..„J Cell Physiol”.211(3),s.590-7,Jun2007. DOI: 10.1002/jcp.21001. PMID: 17311282.
A.Marson,K.Kretschmer,GM.Frampton,ES.Jacobseni inni.Foxp3 occupancy and regulation of key target genes during T-cell stimulation..„Nature”.445(7130),s.931-5,Feb2007. DOI: 10.1038/nature05478. PMID: 17237765.
CL.Bennett,R.Yoshioka,H.Kiyosawa,DF.Barkeri inni.X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3..„Am J Hum Genet”.66(2),s.461-8,Feb2000. DOI: 10.1086/302761. PMID: 10677306.
M.Takenaka,N.Seki,U.Toh,S.Hattorii inni.FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis..„Mol Clin Oncol”.1(4),s.625-632,Jul2013. DOI: 10.3892/mco.2013.107. PMID: 24649219.
KY.Won,HS.Kim,JY.Sung,GY.Kimi inni.Tumoral FOXP3 has potential oncogenic function in conjunction with the p53 tumor suppressor protein and infiltrated Tregs in human breast carcinomas..„Pathol Res Pract”.209(12),s.767-73,Dec2013. DOI: 10.1016/j.prp.2013.08.010. PMID: 24071443.
CL.Bennett,J.Christie,F.Ramsdell,ME.Brunkowi inni.The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3..„Nat Genet”.27(1),s.20-1,Jan2001. DOI: 10.1038/83713. PMID: 11137993.